Even pharmaceutical companies are struggling to find their way through a global health crisis

  • 📰 nationalpost
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 80%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Kevin Carmichael: Turns out the white coats are as confused as the rest of us

A pharmaceutical company seems like a good place to go for some insight into the COVID-19 crisis, so I got in touch with Bausch Health Cos. Inc., Canada’s most important drugmaker.

“We see a return to business starting in the third quarter, the July time frame,” he said on June 4. “As to how far, how fast? It depends.” COVID-19 has killed some 410,000 people, sickened more than seven million others and pushed tens of millions into unemployment. Bausch, formerly Valeant Pharmaceuticals International Inc., the disgraced firm that was once the country’s most valuable publicly traded company, has so far missed the wave that has carried other health-care companies higher over the past couple of months — its shares are down about 40 per cent from the start of the year. Otherwise, Papa has been holding his own against his peers by boosting revenue, narrowing losses and paying off the mountain of debt he inherited when he took over in 2016.

“We’re doing a lot of things to try to expand our footprint in Canada and I expect that will continue,” Papa said.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

The National Post has been infected by intersectional zealots. Feel free to cancel your subscriptions.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 10. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인